Altria Group, Inc. (MO)
MO Optimize & Accelerate Initiative: Enough to Boost Long-Term EPS?
Altria's Optimize & Accelerate program reinvests cost savings to fuel smoke-free growth and long-term EPS.
Altria Rises 12% in 3 Months: Should You Buy, Sell or Hold the Stock?
MO's 12% 3-month surge highlights strong earnings, rising smoke-free sales and disciplined execution amid industry weakness.
Altria: The Company Is Ready To Make A Move Into The Smokeless Segment
Altria is rated a buy, with its stable business model, high margins, and strong cash flow supporting solid returns and income. MO has moved past the failed JUUL acquisition, maintaining robust core operations and expanding into higher-margin smokeless products with new partnerships. Second-quarter results beat expectations, with EPS up 6% year-over-year, strong cash flow, and rising net margins despite declining cigarette volumes.
Altria: A Safe-Haven Buy As Tariffs Trigger Panic Selling
Altria remains a Buy due to its defensive nature, strong shareholder returns, and undervalued stock price despite ongoing cigarette volume declines. Altria's Q2 2025 results showed resilient EPS growth, expanding margins, and robust free cash flow, driven by pricing power and growth in oral tobacco products. The company's 6.45% dividend yield, ongoing buybacks, and conservative leverage support continued capital returns and financial stability.
Altria (MO) Stock Sinks As Market Gains: Here's Why
Altria (MO) concluded the recent trading session at $64.92, signifying a -2.43% move from its prior day's close.
Altria's Oral Margins Surge to 68.7%: Can the Strength Last?
MO's oral segment OCI margin hits 68.7% as on! pouches boost profitability despite volume dips and rising competition.
Altria: Packs A Stable Punch Amid Macro Unease, 6.5% Dividend Yield
Altria remains a "Buy," with a 6.45% forward dividend yield and solid technical momentum approaching its 2017 all-time high. MO delivered strong Q1 results, driven by growth in oral tobacco products and effective price increases, offsetting cigarette volume declines. Valuation is near full value, but MO offers a robust dividend, steady earnings, and a favorable FCF yield, with a price target near $70-$76.
MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?
Altria's on! nicotine pouch brand captures 8.7% of the U.S. oral tobacco market, fueling growth and brand momentum in a fierce competitive landscape.
Altria (MO) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Altria (MO) stood at $66.65, denoting a +1.96% move from the preceding trading day.
A "Smoke-Free" Partnership Could Breathe New Life Into This Dividend King
Altria Group (MO -0.03%) is not only a Dividend King with over 50 consecutive years of dividend growth. The parent of Marlboro maker Philip Morris USA is currently the highest-yielding Dividend King out there, with a forward yield of 6.45%.
Altria Group, Inc. (NYSE: MO) Price Prediction and Forecast 2025-2030 (October 2025)
Shares of Altria Group Inc. ( NYSE: MO ) lost 1.47% over the past month after gaining 7.36% the month prior.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
